Cellevate

Cellevate participates at GLIA 2023 in Berlin, July 8-11 to promote Cellevat3d™ NanoMatrice™

Cellevate participates at GLIA 2023 in Berlin, July 8-11 to promote Cellevat3d™ NanoMatrice™ – a neuro-scaffold designed for research of the central nervous system LUND,… Read More

Cellevate and Max Planck Society enters into collaboration for research in viral vaccine production

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces that… Read More

Cellevate strengthens its Scientific Advisory Board by appointing Dr. Yvonne Genzel, a vaccine production leading expert

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces that… Read More

Cellevate appoints Dr. Thierry Ziegler, leading expert in biopharmaceutical development to the Scientific Advisory Board

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces that… Read More

Positive feasibility results for AAV vector transfection and production using Cellevat3d™ microcarriers

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announces positive feasibility… Read More

Cellevate expands collaboration with University of Dundee UK to optimize Cellevat3d™ microcarrier use in AAV production

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, has expanded the… Read More

Cellevate’s nanofiber-based technology for Upstream AAV, lentivirus and cell therapy bioproduction, part of AdBIOPRO

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announces that AdBIOPRO… Read More

Cellevate awarded grant to run Cellevat3d™ microcarriers scale-up validation for AAV production at Testa Center

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces that… Read More

Cellevate, KI and Karolinska Univ hospital in collaboration to develop more effective production of stem cell therapies

LUND, Sweden – Cellevate, Karolinska Institutet and Karolinska University Hospital were awarded a grant of 5.25 MSEK in February 2022 from the Swedish Governmental Agency for Innovation… Read More

Leading expert in continuous bioprocess for biologics production appointed to Cellevate’s Scientific Advisory Board

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces that… Read More